Importantly, the inhibition of AMPK signalling is involved in the pro-oxidant role of mutant p53 in cancer cells stimulating mitochondrial ROS production that could produce genomic DNA damage and genomic instability, which are typical hallmarks of cancer cells bearing mutant p53 protein (Cordani et al. 2018). This evidence concerns the gene TP53 and cancer.